Header Logo

Connection

DANIEL LEUNG to Serogroup

Back to Details
This is a "connection" page, showing publications DANIEL LEUNG has written about Serogroup.
DANIEL LEUNG
Connection Strength
0.055
Serogroup
  1. Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge. Vaccine. 2024 10 24; 42(24):126263.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.